Shenzhen Bioeasy Biotechnology Co.,Ltd. Posted 99.2 Million Yuan Net Loss in First Three Quarters of 2023

Shenzhen Bioeasy Biotechnology Co.,Ltd. (深圳市易瑞生物技术股份有限公司) (300942.SZ) reported a net loss of 99.2 million yuan in the first three quarters of 2023, reversing a net profit of 148.3 million yuan for the same period in the previous year.

Meanwhile, the company posted 165.1 million yuan in revenue, down 71.1% year-on-year.

At the end of the reporting period, it had 1.5 billion yuan in total assets and 527 million yuan in total liabilities, with a liability-to-asset ratio of 35.7%.